The Healgen® Immunofluorescence Analyzer OG-H180 is an advanced handheld immunofluorescence analyzer designed for precise and rapid measurement of analyte concentrations in various sample types.
The portable device delivers reliable results within 3 to 15 minutes per diagnostic marker. With a coefficient of variation (CV) below 5%, the device ensures high accuracy and consistency.
| Category | Product Name | Specimen | Catalog No. | Assay Range | Certification |
|---|---|---|---|---|---|
| Anemia | Ferritin | S/P/WB | FFERR-402α | 5-1000 ng/mL | CE |
| Anemia | Folic Acid | S/P | FIFA-302α | 1.5-20 ng/mL | CE |
| Anemia | Vitamin B12 | S/P | FIVB12-302α | 100-1500 pg/mL | CE |
| Cardiovascular | BNP | WB/S/P | FDBNA-402α | 5-5000 pg/mL | CE/NMPA |
| Cardiovascular | Calcitonin | WB/S/P | FECAL-402α | 1.0-1000 pg/mL | CE |
| Cardiovascular | CK-MB | WB/S/P | FDCKM-402α | 2.5-100 ng/mL | CE/NMPA |
| Cardiovascular | cTnI | WB/S/P | FDTRO-402α | 0.1-40 ng/L | CE/NMPA |
| Cardiovascular | cTnI/MYO/CK-MB Combo | WB/S/P | FDCAR-T402α | cTnI: 0.1-40 ng/L; MYO: 10-600 ng/mL; CK-MB: 2.5-100 ng/mL | CE |
| Cardiovascular | cTnI/NT-proBNP | WB/S/P | FDCBT-T402α | cTnI: 0.1-40 ng/L; NT-proBNP: 100-35000 pg/mL | CE |
| Cardiovascular | cTnT | WB/S/P | FDCTT-402α | 30-25000 pg/mL | CE/NMPA |
| Cardiovascular | D-Dimer | WB/S/P | FDDDl-402α | 0.1-10 mg/L | CE/NMPA |
| Cardiovascular | hs-cTnI | WB/S/P | FDTRO-402c | 10-10000 pg/mL | CE/NMPA |
| Cardiovascular | MYO* | WB/S/P | FDMYO-402α | 10-600 ng/mL | CE/NMPA |
| Cardiovascular | NT-proBNP | WB/S/P | FDBNP-402α | 100-35000 pg/mL | CE/NMPA |
| Diabetes | HbA1c | WB | FIHBA-402α | 4-14.5% | CE/NMPA |
| Fertility | AMH | WB/S/P | FAAMH-402α | 0.1-16 ng/mL | CE |
| Fertility | E2 | S/P | FAE2-402α | 15-3000 pg/mL | CE |
| Fertility | FSH | WB/S/P | FAFSH-402α | 1-100 mIU/mL | CE |
| Fertility | LH | WB/S/P | FALH-402α | 1-100 mIU/mL | CE |
| Fertility | PRL | WB/S/P | FAPRL-402α | 1-200 ng/mL | CE |
| Fertility | PROG | WB/S/P | FAPRO-402α | 0.5-60 ng/mL | CE |
| Fertility | Tes | WB/S/P | FKTES-402α | 0.2-15 ng/mL | CE |
| Fertility | β-HCG | WB/S/P | FAHCG-402α | 5-100000 mIU/mL | CE |
| Inflammation | CRP | WB/S/P | FDCRP-402α | 0.6-200 mg/L | CE/NMPA |
| Inflammation | CRP/SAA | WB/S/P | FDSC-T402α | CRP: 0.6-200 mg/L; SAA: 5-300 mg/L | CE |
| Inflammation | IL-6 | WB/S/P | FDIL6-402α | 5-3000 pg/mL | CE/NMPA |
| Inflammation | PCT | WB/S/P | FDPCT-402α | 0.05-100 ng/mL | CE/NMPA |
| Inflammation | SAA | WB/S/P | FDSAA-402α | 0.5-200 mg/L | CE/NMPA |
| Kidney Injury | CysC | WB/S/P | FICYS-402α | 0.50-10.00 mg/L | CE |
| Kidney Injury | MAU | U | FIMAU-102α | 10.0-200 mg/L | CE |
| Kidney Injury | NGAL | WB/S/P/U | FINGA-402α | 50-500 ng/mL | CE |
| Oncology | AFP | WBS | FEAFP-402α | 5-400 ng/mL | CE |
| Oncology | CEA | WBS | FECEA-402α | 1-500 ng/mL | CE/NMPA |
| Oncology | PSA | S/P/WB | FEPSA-502 | 4/10 ng/mL | CE |
| Others | 25-OH VD | S/P/WB | FIVD-402α | 5.0-100.0 ng/mL | CE/NMPA |
| Others | Cortisol | WB/S/P | FKCOR-402α | 50-1000 nmol/L | CE |
| Others | PTH | WB/S/P | FKPTH-402α | 5-3000 pg/mL | CE |
| Others | S100-β | WB/S/P | FIS100-402α | 0.05-10 ng/mL | CE |
| Others | β2-MG | WB/S/P | FIMG-302α | 0.50-20.00 mg/L | CE |
| Respiratory | ADV Ag | Nasal swabs; Nasopharyngeal swabs; Nasal suction fluid | FCADV-502α | / | CE |
| Respiratory | Flu A Ag | Nasal swabs | FCFLU(A)-502α | Flu A ≥1.510^3 TCID50/mL | CE |
| Respiratory | Flu A H5 Ag | Nasal swabs | FCFLU(A/H5)-502α | / | CE |
| Respiratory | Influenza A&B Ag | Nasal swabs | FCFLU(A/B)-502α | Flu A ≥1.510^3 TCID50/mL; Flu B ≥1.510^3 TCID50/mL | CE |
| Respiratory | RSV Ag | Nasal swabs; Nasopharyngeal swabs; Nasal suction fluid | FCRSV-502α | RSV Type A ≥2.710^5 PFU/mL; RSV Type B ≥27.3 TCID50/mL | CE |
| Respiratory | RSV+ADV Ag | Nasal swabs; Nasopharyngeal swabs; Nasal suction fluid | FCRA-T502α | / | CE |
| Respiratory | SARS-CoV-2 Ag | Nasal swabs | FCCOV-502α | COV ≥2.310^4 TCID50/mL | CE |
| Respiratory | SARS-CoV-2/Influenza A&B Ag Combo | Nasal swabs | FCFC-T502α | Flu A ≥1.510^4 TCID50/mL; Flu B ≥1.510^4 TCID50/mL; Flu A+B ≥1.510^4 TCID50/mL; SARS-CoV-2 ≥310^4 TCID50/mL | CE |
| Thyroid | FT3 | S/P | FKT3-402α | 0.60-50.00 pmol/L | CE |
| Thyroid | FT4 | S/P | FKFT4-402α | 0.50-100 pmol/L | CE |
| Thyroid | T3 | S/P/WB | FKT3-402α | 0.61-9.22 nmol/L | CE/NMPA |
| Thyroid | T4 | S/P/WB | FKT4-402α | 12.87-310 nmol/L | CE/NMPA |
| Thyroid | TSH | S/P/WB | FKTSH-402α | 0.3-100 mIU/L | CE/NMPA |
| Toxicology | Fentanyl | Urine | FBFEN-102g | 1.0ng/mL | 510(k)/CLIA-waived |